Wolins’ group reported that transgenic mice with PLIN5 overexpression in skeletal muscle display increased glucose tolerance and resistance to hepatic steatosis, which they attributed to increased serum levels of FGF21 (ref. 50). This evidence concerns the gene PLIN5 and Hepatic steatosis.